Key Highlights
- Lantern to offer Pelago’s personalized SUD treatment starting next year.
- Comprehensive care covers all substances and severities, including alcohol, opioids, and tobacco.
- Pelago integrates telemedicine with in-person treatment backed by peer-reviewed research.
- Addresses a critical gap for the 49 million U.S. workers with SUD or mental health illnesses.
- Lantern’s curated network ensures high-quality, accessible care nationwide.
Source: Direct
Notable Quotes
- “This partnership between Pelago and Lantern marks a significant step forward in delivering comprehensive, high-quality care solutions for employers and their members.” — Frank Jennings, President at Pelago
- “Through Pelago, our clients will soon have access to tailored SUD programs, provided both in-person or via telehealth, that’s backed by science and proven to improve health outcomes.” — Dickon Waterfield, President at Lantern
Why This Matters
The partnership between Lantern and Pelago represents a transformative approach to addressing substance use disorders (SUDs), a critical and growing concern among the U.S. workforce. With 49 million adults affected by SUD or mental health illness, and only a fraction receiving adequate employer support, this collaboration bridges a significant healthcare gap. By combining Lantern’s specialty care expertise with Pelago’s innovative substance use treatment, employers can now provide their teams with personalized, effective care, resulting in better health outcomes and enhanced workforce well-being.
